Bristol-Myers Squibb Co. (BMY) PT Lowered to $69 at Goldman Sachs

October 27, 2023 6:13 AM EDT Send to a Friend

Goldman Sachs analyst Chris Shibutani ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Bristol-Myers Squibb Co. (BMY) PT Lowered to $69 at Goldman Sachs

Member Login

Free News Feed